1 recruiting, 1 unknown. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow Proteinuria in Nephrotic Range: new trials by email Literature Review of Proteinuria in Nephrotic Range trials Research Report on Proteinuria in Nephrotic Range
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sparsentan for the Treatment of VEGF Signaling Pathway Inhibitor-Associated Proteinuria sparsentan, No sparsentan - Proteinuric Renal Disease, Proteinuric Kidney Disease | Phase 1 | Recruiting | Brigham and Women's Hospital | 20 | 2026-07-10 | 2026-07-30 |
| Registry of IgA Nephropathy in Chinese Children Corticosteroid, Cyclophosphamide, Mycophenolate mofetil - IgA Nephropathy, Proteinuria in Nephrotic Range | Unknown | Peking University First Hospital | 1200 | 2016-01-01 | 2023-12-06 |
Glomerulonephritis, IGA (1) · Neoplasms (1) · Proteinuria (1)
Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Male Urogenital Diseases (2) · Urogenital Diseases (2) · Urologic Diseases (2) · Autoimmune Diseases (1) · Glomerulonephritis (1) · Immune System Diseases (1) · Kidney Diseases (1) · Nephritis (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Urination Disorders (1) · Urological Manifestations (1)
Adrenal Cortex Hormones (1) · Angiotensin Receptor Antagonists (1) · Angiotensin-Converting Enzyme Inhibitors (1) · Cyclophosphamide (1) · Dipyridamole (1) · Mycophenolic Acid (1) · Prednisolone (1) · Prednisone (1) · Steroids (1) · deflazacort (1) · sparsentan (1)
Brigham and Women's Hospital (1) · Peking University First Hospital (1)
China (1) · United States (1)
Jie Ding, Prof. (1)